UTHEALTH HOME    ABOUT SBMI    A-Z    WEBMAIL    INSIDE THE UNIVERSITY
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use
Center for Computational Systems Medicine
leaf

Kinase Fusion Gene Summary

leaf

Kinase Fusion Gene Sample Information

leaf

Kinase Fusion ORF Analysis

leaf

Kinase Fusion Amino Acid Sequences

leaf

Multiple Sequence Alignment of All Fusion Protein Isoforms

leaf

Kinase Fusion Protein Functional Features

leaf

Kinase Fusion Protein Structures

leaf

Comparison of Fusion Protein Isoforms

leaf

Comparison of Fusion Protein Sequences/Structures with Known Sequences/Structures from PDB

leaf

pLDDT Scores and Difference Analysis of pLDDT Scores Between the Active Sites (Best) and Non-Active Sites.

leaf

Ramachandran Plot of Kinase Fusion Protein Structure

leaf

Potential Active Site Information

leaf

Virtual Screening Results

leaf

Kinase-Substrate Information

leaf

Related Drugs with This Kinase Fusion Protein

leaf

Related Disease with This Kinase Fusion Protein

leaf

Clinical Trials of the Found Drugs/Small Molecules

Kinase Fusion Gene:AKT2_PIM1

Kinase Fusion Protein Summary

check button Kinase Fusion gene summary
Kinase Fusion partner gene informationKinase Fusion gene name: AKT2_PIM1
KinaseFusionDB ID: KFG277
FusionGDB2.0 ID: KFG277
HgeneTgene
Gene symbol

AKT2

PIM1

Gene ID

208

9361

Gene nameAKT serine/threonine kinase 2lon peptidase 1, mitochondrial
SynonymsHIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETACODASS|LON|LONP|LonHS|PIM1|PRSS15|hLON
Cytomap

19q13.2

19p13.3

Type of geneprotein-codingprotein-coding
DescriptionRAC-beta serine/threonine-protein kinasePKB betaRAC-PK-betamurine thymoma viral (v-akt) homolog-2protein kinase Akt-2protein kinase B betaputative v-akt murine thymoma viral oncoprotein 2rac protein kinase betav-akt murine thymoma viral oncogene hlon protease homolog, mitochondrialhLON ATP-dependent proteasemitochondrial ATP-dependent protease Lonmitochondrial lon protease-like proteinserine protease 15
Modification date2024041320240411
UniProtAcc

P31751

P11309

Ensembl transtripts involved in fusion geneENST idsENST00000311278, ENST00000392038, 
ENST00000424901, ENST00000579047, 
ENST00000581582, 		ENST00000373509, 
ENST00000468243, 
Context (manual curation of fusion genes in KinaseFusionDB)

PubMed: AKT2 [Title/Abstract] AND PIM1 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)AKT2(40740851)-PIM1(37137992), # samples:1
check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneAKT2

GO:0030335

positive regulation of cell migration

25428377

TgenePIM1

GO:0030163

protein catabolic process

37327776

TgenePIM1

GO:0034599

cellular response to oxidative stress

17420247

TgenePIM1

GO:0051603

proteolysis involved in protein catabolic process

8248235|17420247


check buttonKinase Fusion gene breakpoints across AKT2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonKinase Fusion gene breakpoints across PIM1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.


Top

Kinase Fusion Gene Sample Information

check buttonKinase Fusion gene information.
check button Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceSampleHgeneHchrHbpTgeneTchrTbp
ChimerDB4TCGA-RD-A8MW-01AAKT2chr19

40740851

PIM1chr6

37137992



Top

Kinase Fusion ORF Analysis


check buttonKinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB.
HenstTenstHgeneHchrHbpTgeneTchrTbpSeq length
(transcript)		Seq length
(amino acids)

Top

Kinase Fusion Amino Acid Sequences


check button For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq

Multiple Sequence Alignment of All Fusion Protein Isoforms



Top

Kinase Fusion Protein Functional Features


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:40740851/:37137992)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
AKT2

P31751

PIM1

P11309

FUNCTION: AKT2 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Involved in the inhibition of ciliogenesis associated with RAB8-dependent cilia growth (PubMed:31204173). {ECO:0000269|PubMed:31204173}.; FUNCTION: One of the few specific substrates of AKT2 identified recently is PITX2. Phosphorylation of PITX2 impairs its association with the CCND1 mRNA-stabilizing complex thus shortening the half-life of CCND1. AKT2 seems also to be the principal isoform responsible of the regulation of glucose uptake. Phosphorylates C2CD5 on 'Ser-197' during insulin-stimulated adipocytes. AKT2 is also specifically involved in skeletal muscle differentiation, one of its substrates in this process being ANKRD2. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. Phosphorylates CLK2 on 'Thr-343'.FUNCTION: Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis (PubMed:15528381, PubMed:1825810, PubMed:31548394). Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3) (PubMed:18593906). Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity (By similarity). The stabilization of MYC exerted by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis (By similarity). Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1 (By similarity). Phosphorylation of MAP3K5, another proapoptotic protein, by PIM1, significantly decreases MAP3K5 kinase activity and inhibits MAP3K5-mediated phosphorylation of JNK and JNK/p38MAPK subsequently reducing caspase-3 activation and cell apoptosis (PubMed:19749799). Stimulates cell cycle progression at the G1-S and G2-M transitions by phosphorylation of CDC25A and CDC25C (PubMed:16356754). Phosphorylation of CDKN1A, a regulator of cell cycle progression at G1, results in the relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein stability (PubMed:12431783). Promotes cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression, CDKN1B, at both transcriptional and post-translational levels (PubMed:18593906). Phosphorylation of CDKN1B, induces 14-3-3 proteins binding, nuclear export and proteasome-dependent degradation (PubMed:18593906). May affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3 (PubMed:10664448). Acts also as a regulator of homing and migration of bone marrow cells involving functional interaction with the CXCL12-CXCR4 signaling axis (By similarity). Acts as a positive regulator of mTORC1 signaling by mediating phosphorylation and inhibition of DEPDC5 component of the GATOR1 complex (PubMed:31548394). Also phosphorylates and activates the ATP-binding cassette transporter ABCG2, allowing resistance to drugs through their excretion from cells (PubMed:18056989). Promotes brown adipocyte differentiation (By similarity). {ECO:0000250|UniProtKB:P06803, ECO:0000269|PubMed:10664448, ECO:0000269|PubMed:12431783, ECO:0000269|PubMed:15528381, ECO:0000269|PubMed:16356754, ECO:0000269|PubMed:18056989, ECO:0000269|PubMed:1825810, ECO:0000269|PubMed:18593906, ECO:0000269|PubMed:19749799, ECO:0000269|PubMed:31548394}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

* Minus value of BPloci means that the break pointn is located before the CDS.

check button - Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt).
PartnerHgeneeneHbpTgeneeneTbpENSTBPexonTotalExonProtein feature lociBPlociTotalLenFeatureNote


check button - Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt).
PartnerHgeneeneHbpTgeneeneTbpENSTBPexonTotalExonProtein feature lociBPlociTotalLenFeatureNote


Top

Kinase-Substrate Information of AKT2_PIM1


check button Phosphorylation target of the kinase
(phosphosite, 03-17-2024)
KinaseKinase UniProt AccKinase speciesSubstrateSubstrate UniProt AccSubstrate phosphorylated residuesSubstrate phosphorylated sites (+/-7AA)Domain
AKT2P31751humanATP7AQ04656S1424SYELPARsQIGQKsP
AKT2P31751humanPKP1Q13835S63ssQsstLsHsNRGsM
AKT2P31751humanIRF3Q14653T180sPsLDNPtPFPNLGP
AKT2P31751humanEGFRP00533S229rCrGKSPsDCCHNQCFurin-like
AKT2P31751humanPKP1Q13835T179LGsKGQKttQNRysF
AKT2P31751humanEZRP15311T567QGRDkyKtLRQIRQGERM_C
AKT2P31751humanCBY1Q9Y3M2S20TPPRKsAsLSNLHsLChibby
AKT2P31751humanHSF1Q00613S230PkYSRQFsLEHVHGS
AKT2P31751humanBMI1P35226S316ANRPRKssVNGSSAT
AKT2P31751humanADARP55265T1033RLGERLRtMSCSDKIA_deamin
AKT2P31751humanPKP1Q13835S191ysFystCsGQKAIKK
AKT2P31751humanFLNCQ14315S2233LGRERLGsFGsItRQFilamin
AKT2P31751humanPKP1Q13835T180GsKGQKttQNRysFy
AKT2P31751humanIRS2Q9Y4H2S365sCRVRtAsEGDGGAA
AKT2P31751humanH3C1P68431S10tkQtArkstGGkAPrHistone
AKT2P31751humanWIPF1O43516T398TSRALPAtPQLPSrS
AKT2P31751humanPKP1Q13835S127ysQMENWsRHYPRGS
AKT2P31751humanEDC3Q96F86S161sFRRRHNsWssssRHEdc3_linker
AKT2P31751humanATP7AQ04656S1466ysRAsINsLLsDkRs
AKT2P31751humanPKP1Q13835S118EPDNRRFssysQMEN
AKT2P31751humanPHB2Q99623S91RARPRkIssPTGSkDBand_7
AKT2P31751humanCHUKO15111T23EMRERLGtGGFGNVCPkinase
AKT2P31751humanPHB2Q99623S176TERAKDFsLILDDVABand_7
AKT2P31751humanH3C1P68431S28ATkAArksAPATGGVHistone
AKT2P31751humanADARB1P78563T553LQGERLLtMSCSDKIA_deamin
AKT2P31751humanPKP1Q13835S65QsstLsHsNRGsMyD
AKT2P31751humanLMNAP02545S390EEErLRLsPsPtsQR
AKT2P31751humanATP7AQ04656S1463IVNysRAsINsLLsD
AKT2P31751humanPKP1Q13835T171RGtLRKGtLGsKGQK
AKT2P31751humanPKP1Q13835T82ADNyNyGttsRssYy
AKT2P31751humanIRF3Q14653S175PQPLRsPsLDNPtPF
AKT2P31751humanPPIFP30405S31LPAARACsKGsGDPS
AKT2P31751humanPKP1Q13835T61sKssQsstLsHsNRG
AKT2P31751humanGAPDHP04406T237GMAFrVPtANVsVVDGp_dh_C
AKT2P31751humanPKP1Q13835S69LsHsNRGsMyDGLAD
AKT2P31751humanPKP1Q13835S174LRKGtLGsKGQKttQ
AKT2P31751humanLMNAP02545S404RsRGRAssHssQtQG
AKT2P31751humanPKP1Q13835S54MTVKRQKsKssQsst
AKT2P31751humanMAP3K5Q99683S83ATRGRGssVGGGSrR
AKT2P31751humanHTRA2O43464S212RVRVRLLsGDTYEAVTrypsin_2; Peptidase_M50
AKT2P31751humanPKP1Q13835S185KttQNRysFystCsG
AKT2P31751humanXIAPP98170S87VGRHRKVsPNCRFINBIR
AKT2P31751humanPKP1Q13835S57KRQKsKssQsstLsH
AKT2P31751humanIRF3Q14653S14RILPWLVsQLDLGQLIRF
AKT2P31751humanCYCSP99999Y47ktGQAPGysytAANkCytochrom_C
AKT2P31751humanIRS2Q9Y4H2S1149GGRRRHssEtFSsTt
AKT2P31751humanUPF1Q92900T151FCNGRGNtSGSHIVNUPF1_Zn_bind
AKT2P31751humanGATA6Q92908-2S290KPQKRVPsSRRLGLS
AKT2P31751humanESR1P03372S167GGRERLAsTNDkGSMOest_recep
AKT2P31751humanPKP1Q13835T166LyCDPRGtLRKGtLG
AKT2P31751humanPKP1Q13835T189NRysFystCsGQKAI
AKT2P31751humanFSCN1Q16658T403GCRkVTGtLDANRSSFascin
AKT2P31751humanRACGAP1Q9H0H5T249WTRSRRktGtLQPWN
AKT2P31751humanIRS2Q9Y4H2S306EFRPRsksQssGssA
AKT2P31751humanRPS6KA3P51812T115KVRDRVRtKMERDIL
AKT2P31751humanNF2P35240S10GAIASRMsFSsLkRK
AKT2P31751humanPKP1Q13835S188QNRysFystCsGQKA
AKT2P31751humanPKP1Q13835S84NyNyGttsRssYySK
AKT2P31751humanPKP1Q13835S60KsKssQsstLsHsNR
AKT2P31751humanPKP1Q13835S121NRRFssysQMENWsR
AKT2P31751humanKHSRPQ92945S193GLPERsVsLtGAPEsKH_1
AKT2P31751humanPIP5K1CO60331S555RYRRRtQssGQDGRP
AKT2P31751humanMAT1AQ00266T202VIPVRIHtIVISVQHS-AdoMet_synt_M
AKT2P31751humanHSF1Q00613S326ssVDtLLsPTALIDsVert_HS_TF
AKT2P31751humanCTNNB1P35222S552QDtQRRtsMGGtQQQ
AKT2P31751humanANKRD2Q9GZV1S99QERVRKTsLDLRREI
AKT2P31751humanIRS2Q9Y4H2S577GLRKRtysLttPARQ
AKT2P31751humanIRF3Q14653T207EEWEFEVtAFYRGRQIRF-3
AKT2P31751humanC2CD5Q86YS7S197EARQRLIsLMsGELQ
AKT2P31751humanSH3RF1Q7Z6J0S304KNTKKRHsFtsLtMA
AKT2P31751humanPDK1Q15118T346APRPRVEtsRAVPLAHATPase_c
AKT2P31751humanPKP1Q13835S59QKsKssQsstLsHsN
AKT2P31751humanH3C1P68431T45PHryrPGtVALrEIRHistone
AKT2P31751humanPKP1Q13835S119PDNRRFssysQMENW
AKT2P31751humanEPRS1P07814S999NQGGGLsssGAGEGQ
AKT2P31751humanWIPF1O43516S154PGrFPVPsPGHRSGP
AKT2P31751humanPKP1Q13835S56VKRQKsKssQsstLs
AKT2P31751humanMAT1AQ00266S180LPWLRPDsKTQVTVQS-AdoMet_synt_M
PIM1P11309humanLDHAP00338S161PkNrVIGsGCNLDsA
PIM1P11309humanUHRF1Q96T88-2S311DNPMRRKsGPSCKHC
PIM1P11309humanCAPZA1P52907S126SWREsCDsALRAYVkF-actin_cap_A
PIM1P11309humanCDKN1AP38936S146GRkRRQtsMTDFyHs
PIM1P11309humanDNM1LO00429S637VPVARKLsAREQRDC
PIM1P11309humanMARK3P27448-3T95DKtQLNPtsLQKLFRPkinase
PIM1P11309humanCBX8Q9HC52S196PssPGDSsKKRGPKP
PIM1P11309humanNFATC1O95644S245PSTsPRAsVTEEsWL
PIM1P11309humanRUNX3Q13761T155ksFtLtItVFTNPTQRunt
PIM1P11309humanNFATC1O95644S269PCNKRKYsLNGRQPP
PIM1P11309humanYWHAZP63104S64ssWRVVssIEQkTEG14-3-3
PIM1P11309humanDEPDC5O75140S1530QQRRRRNstSSTNQNDEPDC5_CTD
PIM1P11309humanCDKN1BP46527T157GIRkrPAtDDSSTQN
PIM1P11309humanNKX3-1Q99801S186TKRkQLssELGDLEK
PIM1P11309humanMDM2Q00987S186RQRkRHksDsIsLsF
PIM1P11309humanH3C1P68431S10tkQtArkstGGkAPrHistone
PIM1P11309humanNFATC1O95644T154SSKRsPstATLsLPs
PIM1P11309humanABCG2Q9UNQ0T362GEkKKKItVFKEISY
PIM1P11309humanSKP2Q13309T417WGIkCRLtLQkPSCL
PIM1P11309humanSTK11Q15831S334DTKDRWRsMtVVPYL
PIM1P11309humanNFATC1O95644S151VLPSSKRsPstATLs
PIM1P11309humanSTAT5BP51692S731TyMDQAPsPAVCPQA
PIM1P11309humanARP10275T851ACkRkNPtSCSRRFyHormone_recep
PIM1P11309humanNKX3-1Q99801S195LGDLEKHssLPALKE
PIM1P11309humanNKX3-1Q99801S196GDLEKHssLPALKEE
PIM1P11309humanNFATC1O95644S153PSSKRsPstATLsLP
PIM1P11309humanNFATC1O95644T339PVKsRkttLEQPPsV
PIM1P11309humanMYCP01106S308GHskPPHsPLVLkrCMyc_N
PIM1P11309humanARP10275S215SGRAREAsGAPtsSKAndrogen_recep
PIM1P11309humanCDKN1AP38936T145QGRkRRQtsMTDFyH
PIM1P11309humanLDHAP00338S319EEARLkksADtLWGILdh_1_C
PIM1P11309humanHBP1O60381S372SAVYVLSsMARQRrA
PIM1P11309humanNFATC1O95644S335GDGVPVKsRkttLEQ
PIM1P11309humanCAPZBP47756-1S226DMENkIRsTLNEIyFF_actin_cap_B
PIM1P11309humanNKX3-1Q99801S185KTKRkQLssELGDLE
PIM1P11309humanSKP2Q13309S64sNLGHPEsPPRkRLk
PIM1P11309humanEIF4BP23588S406RPRERHPsWRsEEtQ
PIM1P11309humanSKP2Q13309S72PPRkRLkskGsDkDF
PIM1P11309humanMAP3K5Q99683S83ATRGRGssVGGGSrR
PIM1P11309humanBADQ92934S75EIRsRHssyPAGtEDBcl-2_BAD
PIM1P11309humanARP10275S220EAsGAPtsSKDNyLGAndrogen_recep
PIM1P11309humanRUNX3Q13761S149GRSGRGksFtLtItVRunt
PIM1P11309humanPOU5F1Q01860S288RRQKGKRsssDyAQR
PIM1P11309humanIRS1P35568S1101GCRRRHssEtFsStP
PIM1P11309humanABI2Q9NYB9S183PPtQKPPsPPMsGKG
PIM1P11309humanMDM2Q00987S166SsRRRAIsEtEENsD
PIM1P11309humanFOXO3O43524T32QsRPRsCtWPLQRPE
PIM1P11309humanCAPZBP47756-1T186tNKsGsGtMNLGGsLF_actin_cap_B
PIM1P11309humanNOS3P29474S633WRRKRKEssNtDsAGFlavodoxin_1
PIM1P11309humanIRS2Q9Y4H2S1149GGRRRHssEtFSsTt
PIM1P11309humanCDKN1BP46527T198PGLRRRQt_______
PIM1P11309humanHIF1AQ16665T455LAMsPLPtAEtPkPL
PIM1P11309humanNFATC1O95644S256EsWLGARssRPAsPC
PIM1P11309humanHBP1O60381S380MARQRrAsLsCGGPG
PIM1P11309humanPSMD2Q13200S361ENNrFGGsGsQVDsA
PIM1P11309humanRUNX3Q13761T151SGRGksFtLtItVFTRunt
PIM1P11309humanMARK3P27448-3T90AIKIIDKtQLNPtsLPkinase
PIM1P11309humanCAPZA1P52907S106DHLRkEAsDPQPEEAF-actin_cap_A
PIM1P11309humanRELAQ04206S276sMQLRRPsDRELsEPRHD_dimer
PIM1P11309humanNDRG1Q92597S330LMRsRtAsGssVtsL
PIM1P11309humanNFATC1O95644S257sWLGARssRPAsPCN
PIM1P11309humanEPAS1Q99814S435GKAILPPsQPWATEL
PIM1P11309humanNFATC1O95644T338VPVKsRkttLEQPPs
PIM1P11309humanCAPZBP47756-1S192GtMNLGGsLtRQMEkF_actin_cap_B
PIM1P11309humanPOU5F1Q01860S289RQKGKRsssDyAQRE
PIM1P11309humanCXCR4P61073S339GkrGGHssVstEsEs
PIM1P11309humanNKX3-1Q99801T89AAPEEAEtLAEtEPE
PIM1P11309humanMARK3P27448-3S96KtQLNPtsLQKLFREPkinase
PIM1P11309humanRUNX3Q13761T153RGksFtLtItVFTNPRunt
PIM1P11309humanFOXO3O43524S253APRRRAVsMDNSNkY
PIM1P11309humanNFATC1O95644S278NGRQPPYsPHHsPTP
PIM1P11309humanFOXP3Q9BZS1S422KkRsQRPsRCSNPTP


check button Biological Network Integration of This Kinase and Substrates
(GeneMANIA website)

check button Enriched GO biological processes of the phosphorylation target genes of the kinase
KinaseGOIDGO termP.adjust
AKT2IDDescription0.00e+00
AKT2GO:0034599cellular response to oxidative stress9.95e-05
AKT2GO:0062197cellular response to chemical stress2.64e-04
AKT2GO:0034614cellular response to reactive oxygen species4.30e-04
AKT2GO:0071276cellular response to cadmium ion4.30e-04
AKT2GO:0043281regulation of cysteine-type endopeptidase activity involved in apoptotic process4.30e-04
AKT2GO:0006979response to oxidative stress5.07e-04
AKT2GO:0052548regulation of endopeptidase activity5.85e-04
AKT2GO:2000116regulation of cysteine-type endopeptidase activity7.62e-04
AKT2GO:0052547regulation of peptidase activity7.73e-04
AKT2GO:0000302response to reactive oxygen species8.13e-04
AKT2GO:0046686response to cadmium ion1.24e-03
AKT2GO:0008631intrinsic apoptotic signaling pathway in response to oxidative stress1.40e-03
AKT2GO:0002221pattern recognition receptor signaling pathway1.40e-03
AKT2GO:2001234negative regulation of apoptotic signaling pathway1.54e-03
AKT2GO:0071456cellular response to hypoxia1.77e-03
AKT2GO:0002758innate immune response-activating signaling pathway1.77e-03
AKT2GO:0032481positive regulation of type I interferon production1.78e-03
AKT2GO:0043122regulation of canonical NF-kappaB signal transduction1.95e-03
AKT2GO:0036294cellular response to decreased oxygen levels1.99e-03
AKT2GO:0002218activation of innate immune response2.19e-03
AKT2GO:0051402neuron apoptotic process2.19e-03
AKT2GO:0045088regulation of innate immune response2.35e-03
AKT2GO:0071453cellular response to oxygen levels2.61e-03
AKT2GO:0048732gland development2.61e-03
AKT2GO:0001666response to hypoxia2.61e-03
AKT2GO:0048145regulation of fibroblast proliferation2.61e-03
AKT2GO:0007249canonical NF-kappaB signal transduction2.61e-03
AKT2GO:0010464regulation of mesenchymal cell proliferation2.82e-03
AKT2GO:0032872regulation of stress-activated MAPK cascade2.85e-03
AKT2GO:0070302regulation of stress-activated protein kinase signaling cascade2.98e-03
AKT2GO:0036293response to decreased oxygen levels2.99e-03
AKT2GO:0097193intrinsic apoptotic signaling pathway3.10e-03
AKT2GO:0002757immune response-activating signaling pathway3.10e-03
AKT2GO:0043123positive regulation of canonical NF-kappaB signal transduction3.12e-03
AKT2GO:0043086negative regulation of catalytic activity3.20e-03
AKT2GO:0071248cellular response to metal ion3.24e-03
AKT2GO:0010863positive regulation of phospholipase C activity3.32e-03
AKT2GO:0071392cellular response to estradiol stimulus3.37e-03
AKT2GO:0010586miRNA metabolic process3.37e-03
AKT2GO:0048144fibroblast proliferation3.37e-03
AKT2GO:1900274regulation of phospholipase C activity3.37e-03
AKT2GO:0002764immune response-regulating signaling pathway3.37e-03
AKT2GO:0045089positive regulation of innate immune response3.37e-03
AKT2GO:0070482response to oxygen levels3.37e-03
AKT2GO:0045216cell-cell junction organization3.57e-03
AKT2GO:0032355response to estradiol3.87e-03
AKT2GO:0010463mesenchymal cell proliferation4.42e-03
AKT2GO:0071241cellular response to inorganic substance4.51e-03
AKT2GO:0002833positive regulation of response to biotic stimulus4.51e-03

Top

Related Drugs to AKT2_PIM1


check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

check button Distribution of the number of studies mentioning AKT2-PIM1 and kinase inhibitors the PubMed Abstract (04-01-2024)

Fusion gene - drug pair 1Fusion gene - drug pair 2PMIDPublication dateDOIStudy title

Top

Related Diseases to AKT2_PIM1


check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Related diseases from the literature mentioned this fusion gene and drug.
(PubMed, 04-01-2024)
MeSH IDMeSH term

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource


Top

Clinical Trials of the Found Drugs/Small Molecules


check button Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024)

check button Clinical Trials from clinicaltrials.gov (06-17-2024)

Fusion GeneKinase InhibitorNCT IDStudy StatusPhasesDisease# EnrolmentDate